Investor Relations
We wish to inform all interested parties that the shares of RichReach Corporation Public Ltd are listed at the Emerging Capital Market of the Cyprus Stock Exchange with the codes EUMBR and ΕΟΜΠΡ (that reflects the previous name of the company)
Timeline & Announcements
Financial
Financial
Board of Directors Meeting to review the Company’s 2023 half-yearly Unaudited Consolidated Financial Statements
Announcement at the CSE
Shareholders
Exercise Period of 7,709 Stock Options Shares
Announcement at the CSE
Stock Options Exercised
Shareholders
Notice of the Annual General Meeting of 08/06/2023 at 04:00 pm
Instrument of Proxy
2022 Audited Consolidated Financial Statements
Announcement at the CSE
Financial
Board of Directors Meeting to review the Company’s 2022 Audited Consolidated Financial Statements
Announcement at the CSE
Corporate
Resignation of Mr Epaminondas Metaxas from the office of Directors of the Company
Announcement at the CSE
Operations
Annual Bulletin
Information on the implementation status of the Company's Business Plan/Objectives as at 31/12/2022
Announcement at the CSE
Financial
Financial
Board of Directors Meeting to review the Company’s 2022 half-yearly Unaudited Consolidated Financial Statements
Announcement at the CSE
Shareholders
Exercise Period of 16,250 Stock Options Shares
Announcement at the CSE
Stock Options Exercised
Shareholders
Notice of the Annual General Meeting of 10/06/2022 at 10:00 am
Instrument of Proxy
2021 Audited Consolidated Financial Statements
Announcement at the CSE
Financial
Board of Directors Meeting to review the Company’s 2021 Audited Consolidated Financial Statements
Announcement at the CSE
Operations
Annual Bulletin
Information on the implementation status of the Company's Business Plan/Objectives as at 31/12/2021
Announcement at the CSE
Financial
Financial
Board of Directors Meeting to review the Company’s 2021 half-yearly Unaudited Consolidated Financial Statements
Announcement at the CSE
Shareholders
Signing of Share Purchase Agreement with Charis Tymvios
Announcement at the CSE
Corporate
Appointment of Mr George Koufaris to the position of non-executive Chairman of the Board of Directors
Announcement at the CSE
Shareholders
Notice of the Annual General Meeting of 08/07/2021 at 09:00 am
Instrument of Proxy
2020 Audited Consolidated Financial Statements
Announcement at the CSE
Financial
Board of Directors Meeting to review the Company’s 2020 Audited Consolidated Financial Statements
Announcement at the CSE
Operations
Annual Bulletin
Information on the implementation status of the Company's Business Plan/Objectives as at 31/12/2020
Announcement at the CSE
Shareholders
Signing of Share Purchase Agreement with C.A. Papaellinas Ltd
Announcement at the CSE
Financial
Financial
Board of Directors Meeting to review the Company’s 2020 half-yearly Unaudited Consolidated Financial Statements
Announcement at the CSE
Shareholders
Notice of the Annual General Meeting of 22/07/2020 at 09:00 am
Instrument of Proxy
2019 Audited Consolidated Financial Statements
Announcement at the CSE
Shareholders
Signing of Share Purchase Agreement with C.A. Papaellinas Ltd
Announcement at the CSE
Operations
Effect of COVID-19 on the Company
Announcement of 27/04/2020 at the CSE
Announcement of 12/03/2020 at the CSE
Shareholders
Decision of the Board of Directors to offer Stock Options to all the Company’s employees, directors and full time external contractors
Announcement at the CSE
Operations
Appointment of VGDA Accountants Limited as the Company’s new Nominated Advisor
Announcement at the CSE
Operations
“RichReach” has been registered as a European Union Trademark in the Register of European Union trade marks (EUIPO)
Trademark Certificate
Operations
Annual Bulletin
Information on the implementation status of the Company's Business Plan/Objectives
Announcement at the CSE
Shareholders
Allotment of 96,778 additional fully paid shares
Announcement 1 at the CSE
Announcement 2 at the CSE
Financial
Financial
Board of Directors Meeting to review the Company’s 2019 half-yearly Unaudited Consolidated Financial Statements
Announcement at the CSE
Corporate
Completion of the increase of the Company’s Authorised Ordinary Share Capital
Announcement at the CSE
Corporate
Completion of the Appointment of Mr Epaminondas Metaxas and Mr George Koufaris at the office of Directors of the Company
Announcement at the CSE
Shareholders
Notice of the Annual General Meeting of 03/07/2019 at 12:00 pm
Announcement at the CSE
Corporate
Completion of the Change of Name of “eUmbrella Corporation (International) Public Ltd” to “RichReach Corporation Public Ltd”
Announcement at the CSE
Shareholders
Extraordinary General Meeting
Shareholders
Notice of the Extraordinary General Meeting of 10/04/2019 at 14:00
Announcement at the CSE
Shareholders
Signing of Share Purchase Agreement with C.A. Papaellinas Ltd
Shareholders
Signing of Share Purchase Agreement with
Cyprus Pharmaceutical Organisation Ltd
Corporate
Appointment of Mr. Kyprianos Kyprianou to the position of CEO
Announcement at the CSE
Corporate
Start of trading of the Company’s Shares at the Emerging Companies Market (ECM) of the
Cyprus Stock Exchange (CSE)
Announcement at the CSE
Shareholders
Deadline for Applications regarding the Notice of Pre-Emptions Rights dated 10/08/2018
Shareholders
Notice of Pre-Emptions Rights
(raising of the issued share capital by €1,500,000)
Deadline for Applications: 17/09/2018
Corporate
Completion of the increase of the Company’s Authorised and Issued Ordinary Share Capital
Shareholders
Unanimous written Resolution signed by all the shareholders of the Company to increase the Company’s Authorised and Issued Ordinary Share Capital.
Operations
eUmbrella Corporation (International) Public Ltd acquires 100% of eUmbrella Corporation (CY) Ltd
Financial
Financial Reports & Presentations
2023 6-month Unaudited Consolidated Financial Statements
2022 Audited Consolidated Financial Statements
2022 6-month Unaudited Consolidated Financial Statements
2021 Audited Consolidated Financial Statements
2021 6-month Unaudited Consolidated Financial Statements
2020 Audited Consolidated Financial Statements
2020 6-month Unaudited Consolidated Financial Statements
2019 Audited Consolidated Financial Statements
2019 6-month Unaudited Consolidated Financial Statements
2018 Annual Audited Consolidated Financial Statements
2018 6-month Unaudited Consolidated Financial Statements